The study of nateglinide and insulin, vitamin E succinate and insulin combinations loaded into DEX-based micelles reduced oxidative stress and improved the mitochondrial function and glucose metabolism, while also improving the cognitive capacity of mice, demonstrating a paradigm for specific and high-efficacy combination therapy for Alzheimer’s disease [139]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.